A detailed history of William Blair Investment Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, William Blair Investment Management, LLC holds 205,689 shares of LGND stock, worth $22.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
205,689
Previous 202,842 1.4%
Holding current value
$22.9 Million
Previous $17.1 Million 20.55%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$82.7 - $110.11 $235,446 - $313,483
2,847 Added 1.4%
205,689 $20.6 Million
Q2 2024

Aug 08, 2024

BUY
$68.53 - $87.91 $931,665 - $1.2 Million
13,595 Added 7.18%
202,842 $17.1 Million
Q1 2024

May 08, 2024

BUY
$68.64 - $89.2 $130,759 - $169,926
1,905 Added 1.02%
189,247 $13.8 Million
Q4 2023

Feb 09, 2024

BUY
$49.57 - $72.63 $1.37 Million - $2 Million
27,549 Added 17.24%
187,342 $13.4 Million
Q3 2023

Nov 09, 2023

BUY
$58.86 - $72.67 $287,648 - $355,138
4,887 Added 3.15%
159,793 $9.57 Million
Q2 2023

Aug 10, 2023

BUY
$69.53 - $79.33 $149,628 - $170,718
2,152 Added 1.41%
154,906 $11.2 Million
Q1 2023

May 12, 2023

BUY
$65.67 - $77.08 $763,479 - $896,132
11,626 Added 8.24%
152,754 $11.2 Million
Q4 2022

Feb 09, 2023

SELL
$61.72 - $96.74 $17 Million - $26.7 Million
-275,947 Reduced 66.16%
141,128 $9.43 Million
Q3 2022

Nov 09, 2022

BUY
$0.01 - $107.56 $210 - $2.26 Million
21,031 Added 5.31%
417,075 $35.9 Million
Q2 2022

Aug 10, 2022

SELL
$74.52 - $117.06 $38.6 Million - $60.6 Million
-518,055 Reduced 56.67%
396,044 $35.3 Million
Q1 2022

May 11, 2022

SELL
$94.99 - $151.56 $46.2 Million - $73.7 Million
-486,242 Reduced 34.72%
914,099 $103 Million
Q4 2021

Feb 14, 2022

BUY
$127.69 - $165.85 $3.12 Million - $4.05 Million
24,400 Added 1.77%
1,400,341 $216 Million
Q3 2021

Nov 10, 2021

BUY
$102.33 - $144.73 $13.3 Million - $18.7 Million
129,489 Added 10.39%
1,375,941 $192 Million
Q2 2021

Aug 12, 2021

SELL
$113.03 - $155.64 $5.06 Million - $6.97 Million
-44,802 Reduced 3.47%
1,246,452 $164 Million
Q1 2021

May 13, 2021

SELL
$99.52 - $215.83 $74.6 Million - $162 Million
-749,791 Reduced 36.74%
1,291,254 $197 Million
Q4 2020

Feb 09, 2021

BUY
$80.55 - $106.05 $11.7 Million - $15.4 Million
145,671 Added 7.69%
2,041,045 $203 Million
Q3 2020

Nov 06, 2020

BUY
$89.56 - $126.72 $36.6 Million - $51.8 Million
408,870 Added 27.51%
1,895,374 $181 Million
Q2 2020

Aug 12, 2020

SELL
$68.28 - $123.65 $2.31 Million - $4.18 Million
-33,792 Reduced 2.22%
1,486,504 $166 Million
Q1 2020

May 08, 2020

BUY
$63.37 - $107.88 $6.56 Million - $11.2 Million
103,446 Added 7.3%
1,520,296 $111 Million
Q4 2019

Feb 12, 2020

BUY
$96.94 - $113.59 $7.82 Million - $9.17 Million
80,707 Added 6.04%
1,416,850 $148 Million
Q3 2019

Nov 12, 2019

BUY
$86.25 - $120.16 $37.8 Million - $52.7 Million
438,773 Added 48.9%
1,336,143 $133 Million
Q2 2019

Aug 09, 2019

BUY
$107.38 - $129.34 $1.04 Million - $1.26 Million
9,728 Added 1.1%
897,370 $102 Million
Q1 2019

May 10, 2019

SELL
$105.93 - $142.47 $9.5 Million - $12.8 Million
-89,642 Reduced 9.17%
887,642 $112 Million
Q4 2018

Feb 13, 2019

SELL
$128.36 - $272.13 $6.79 Million - $14.4 Million
-52,891 Reduced 5.13%
977,284 $133 Million
Q3 2018

Nov 13, 2018

SELL
$211.18 - $274.49 $22.6 Million - $29.3 Million
-106,836 Reduced 9.4%
1,030,175 $283 Million
Q2 2018

Aug 14, 2018

BUY
$150.77 - $207.98 $16.3 Million - $22.4 Million
107,900 Added 10.48%
1,137,011 $236 Million
Q1 2018

May 14, 2018

SELL
$138.63 - $182.62 $29.2 Million - $38.5 Million
-210,960 Reduced 17.01%
1,029,111 $170 Million
Q4 2017

Feb 14, 2018

BUY
$128.36 - $147.04 $11.9 Million - $13.6 Million
92,695 Added 8.08%
1,240,071 $170 Million
Q3 2017

Nov 13, 2017

BUY
$120.91 - $137.94 $139 Million - $158 Million
1,147,376
1,147,376 $156 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.